Clinical outcomes of CD3xCD20 bispecific antibodies in patients with central nervous system involvement by lymphoma - Quiz - MDSpire

Clinical outcomes of CD3xCD20 bispecific antibodies in patients with central nervous system involvement by lymphoma

  • By

  • Karan L. Chohan

  • Rina L. Welkie

  • James Godfrey

  • Steven Bair

  • Lorenzo Falchi

  • Manali Kamdar

  • Ajay Major

  • Wendy Dixon

  • Jennifer Crombie

  • Reid Merryman

  • Sonia Godbole

  • Gilles Salles

  • Omnia Farahat

  • Amy Ayers

  • Ayushi Chauhan

  • Alex Herrera

  • Geoffrey Shouse

  • Sairah Ahmed

  • Yazeed Sawalha

  • May 22, 2026

  • 0 min

Share

Original Source(s)

Clinical outcomes of CD3xCD20 bispecific antibodies in patients with central nervous system involvement by lymphoma

  • by Karan L. Chohan, Rina L. Welkie, James Godfrey, Steven Bair, Lorenzo Falchi, Manali Kamdar, Ajay Major, Wendy Dixon, Jennifer Crombie, Reid Merryman, Sonia Godbole, Gilles Salles, Omnia Farahat, Amy Ayers, Ayushi Chauhan, Alex Herrera, Geoffrey Shouse, Sairah Ahmed, Yazeed Sawalha

  • May 22, 2026

Related Content

Diffuse large B-cell lymphoma presenting as a scalp tumor with skull destruction and neurological symptoms: a case report

PD-1 inhibitor combined with chemoradiotherapy in two cases of ovarian cancer brain metastases: a case report

Stimuli-responsive nanoplatforms for sonodynamic immunotherapy: opportunities and challenges in cancer treatment